CCR9 and acute lymphoblastic leukemia: Here, we report the generation and characterization of 92R, an anti-CCR9 mAb able to selectively inhibit in vivo growth of human acute T-ALL cells transplanted into immunodeficient Rag2−/− or NSG mice.